Quote this publication Share Print


Opinions on drugs - Posted on Jun 23 2014

Reason for request



Actual benefit


The actual benefit of subcutaneous (SC) HERCEPTIN is substantial.

Improvement in actual benefit

V (absence)

The new subcutaneous formulation of HERCEPTIN is an addition to the range, complementing the intravenous formulation of HERCEPTIN that is currently available.
Consequently, subcutaneous HERCEPTIN does not provide any improvement in actual benefit (level V, non-existent) compared with intravenous HERCEPTIN.